Quarterly report pursuant to Section 13 or 15(d)

Equity Instruments - Contingent Earnout Liabilities, Fair Value Assumptions (Details)

v3.22.1
Equity Instruments - Contingent Earnout Liabilities, Fair Value Assumptions (Details)
Mar. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Expected Term (years) 4 years 6 months 4 years 9 months
Current stock price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, measurement input 9.31 7.81
Expected volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, measurement input 0.508 0.525
Risk-free interest rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, measurement input 0.024 0.012
Dividend rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Business combination, measurement input 0 0